无治疗缓解期慢性髓性白血病患者可测量残留病的谱系来源
该研究采用流式分选结合BCR-ABL1 DNA PCR,分析20例无治疗缓解超过1年的慢性髓性白血病患者血液中残留细胞的谱系分布。结果显示残留病主要存在于淋系,B细胞比T细胞更常阳性且水平更高;诊断时淋系细胞仅占白细胞小部分。提示血液残留病未必代表多能CML细胞持续存在。
要点
- TFR患者血液残留病主要见于淋系,粒细胞中未检出。
- B细胞BCR-ABL1阳性率高于T细胞,且残留水平更高。
- 谱系特异性残留病检测或可改进TFR预测。
核心结论
- TFR患者血液中可测量残留病主要存在于淋系,未必提示多能CML细胞持续存在。
研究设计与样本
- 采用荧光激活细胞分选和BCR-ABL1 DNA PCR,对20例TFR超过1年的CML患者血液分选粒细胞、单核细胞、B细胞、T细胞和NK细胞进行研究。
主要发现
- 残留病主要见于淋系,粒细胞中从未检出。
- B细胞BCR-ABL1阳性患者数多于T细胞(18 vs 11/20),且水平更高(中位10^-4.9 vs 10^-5.7;P = 0.014)。
- 在13例诊断时研究的CML患者中,表达BCR-ABL1 mRNA的淋巴细胞仅占全部白细胞的一小部分。
临床怎么用
- 血液残留病阳性不一定代表多能CML细胞持续存在。
- 可探索谱系特异性残留病评估以改进TFR预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately half of patients with chronic myeloid leukemia (CML) in sustained deep molecular response who discontinue tyrosine kinase inhibitors (TKIs) remain in treatment-free remission (TFR). Some of these patients have measurable residual disease (MRD) by BCR-ABL1 mRNA testing, and most have detectable BCR-ABL1 DNA by highly sensitive methods. We used fluorescence-activated cell sorting and BCR-ABL1 DNA PCR to investigate the lineage of residual CML cells in TFR. Twenty patients in TFR for >1 year provided blood for sorting into granulocytes, monocytes, B cells, T cells, and NK cells. MRD was identified predominantly in the lymphoid compartment and never in granulocytes. B cells were more often BCR-ABL1 positive than T cells (18 vs 11/20 patients) and at higher levels (median 10-4.9 vs 10-5.7; P = 0.014). In 13 CML patients studied at diagnosis lymphocytes expressing BCR-ABL1 mRNA comprised a small proportion of total leukocytes. These data improve our understanding of TFR biology, since it is now clear that MRD in the blood of TFR patients need not imply the persistence of multipotent CML cells. Lineage-specific assessment of MRD could be explored as a means to improve the prediction of TFR.
引用
- Pagani IS, Dang P, Saunders VA, et al. Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission. Leukemia. 2019. PMID: 31768016. doi:10.1038/s41375-019-0647-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。